©2018 Immunicom, Inc. All rights reserved.

6048 CORNERSTONE COURT W

SUITE D, 

SAN DIEGO, CA 92121

  • Black LinkedIn Icon

Thank you for attending our

1st Annual Global Immunopheresis Conference

July 31st - August 2nd, 2019  |  Sheraton Grand Krakow  |  Krakow, Poland

INNOVATIVE SPEAKERS

Piotr Wysocki, M.D., Ph.D., FPSCO 

Prof. Wysocki is an expert in the field of oncology and serves as the Head of Department of Oncology at Jagiellonian University - Medical College Hospital, Cracow, Poland. He graduated from University of Medical Sciences in Poznan, Poland in 2000, and the same year he completed doctoral degree at this university. Between 2001-2007 prof. Wysocki performed residency program in clinical oncology at Greater Poland Cancer Center in Poznan, Poland. His initial scientific interest was devoted to development of various specific immunotherapy approaches based on genetically modified tumor vaccines in animal models and latter in clinical settings. Following completion of medical residency, Prof. Wysocki’s research area has shifted towards clinical and translational studies mainly in breast and genitourinary cancers devoted to elucidation of tumor resistance mechanisms to systemic cancer therapies and evaluation of innovative drugs in clinical settings. He established the first in Poland Early Phase Oncology Clinical Research Unit at West Pommeranian Cancer Center in 2015.

Prof. Wysocki has received numerous scholarships and prizes for his impressive work. Scholarships that he has received are the Polish Ministry of Health Scholarship in 2000; Scholarship of Foundation for Polish Science in 2002 and 2003; and the Scholarship of American Society of Clinical Oncology – IDEA award. Notable prizes he has received are the Nature Immunology prize in 2000 and Polish Prime Minister Prize for outstanding PhD thesis 2002. Prof. Wysocki scientific and clinical training was completed at Dept. of Molecular Biology, Roswell Park Cancer Institute Bufallo, NY (1997) and Dept. of Oncology, Princess Margaret Hospital in Toronto, Canada (2008). Additionally, Prof. Wysocki serves as the President of Polish Society of Clinical Oncology (2015-2019).

Adam Ostrowski, M.D.

Dr. Ostrowski is an internal medicine and medical oncology physician, with broad clinical practice and corporate advisory experience.  Dr. Ostrowski recently served as Chair and Medical Director of Oncology at the Multispecialty Regional Hospital in Gorzow Wielkopolski, Poland.  His clinical expertise covers treatment of all solid tumors. Dr. Ostrowski has been involved in more than 20 phase II-IV clinical trials, where he has served in capacities including Principal Investigator and led activities ranging from protocol development and clinical trial investigator/site selection, to regulatory body and ethics committee submissions, to monitoring audits and managing study closeouts.  He has served as a lead medical consultant and/or advisor to many international companies including Hoffmann La Roche, Actelion Pharmaceuticals, ZLB Behring and Windtree Therapeutics.  He is an active member of numerous international committees providing drug development safety oversight such as the International Safety Assessment Committee for Tracon Pharmaceuticals and the Data Monitoring Committee for Agenus Inc.  Dr. Ostrowski is also Chairman of the regional branch of the National Cancer Registry in Poland.

 

Dr. Ostrowski received his medical degree from the Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poland and his medical oncology training in the Center for Postgraduate Medical Education and Oncology Institute in Warsaw, Poland. 

Steve Prince

Steve Prince is a results-oriented marketing/sales, strategy and business development executive with a 30-year track record of successfully building new growth opportunities and global markets for medical technology companies of all sizes.  He began his career with GE Healthcare where he worked in hospitals across the U.S., Europe and Asia developing the market for nascent technology called positron emission tomography (i.e. PET Imaging), which today is a $2.5 billion global industry. After serving in various VP level roles in Gen-Probe, Cardinal Health, and CareFusion, Steve co-founded CRISI Medical Systems which won the 2015 Frost & Sullivan "North American Award for New Product Innovation", the 2016 "Medical Design Excellence Award (MDEA)" global competition for drug-delivery devices, and was recently acquired by Becton, Dickinson and Co.

Steve received his Bachelor of Science in Electrical Engineering degree from Michigan Tech University, his Master of Science in Electrical Engineering from Marquette University, and his MBA from Northwestern University's Kellogg Graduate School of Management.  He has over a dozen issued US & international patents.

Amir Jafri

Amir Jafri is the founder of Immunicom and has served as its President and Chief Executive Officer since the company’s inception in 2013. Amir has over 25 years of experience in healthcare technology and devices. As a senior executive in Fortune 50 companies and his own startups, he has managed multi-billion-dollar products on a global basis and is highly experienced with global regulatory environments. He was COO at West Health Institute; VP/CTO, VP R&D and VP Operations at Cardinal Health managing products with $1B in annual revenue (NYSE: CAH); VP/General Manager Healthcare Division at Manpower Group, responsible for the healthcare practice nationwide across 35 locations (NYSE: MAN). Prior to joining Manpower, Amir founded various healthcare startups that were subsequently acquired. He has successfully managed global businesses and has a track record of success in every business he has led. Amir serves on the Board of various healthcare technology startup companies and non-profit organizations. Amir received his Bachelors of Science Degree from Houston Baptist University with a double major in Chemistry and Biology and a minor in History. He attended medical school at the University of Texas but pursued an entrepreneurial and corporate path.

 

AGENDA (TENTATIVE)

DAY 

ONE

Wednesday, July 31st

(Invite Only)

12:30 PM

Shuttle Bus Leaves Sheraton to go to Krakow Oncology Department

1:00 PM - 03:00 PM

Presentation of real time plasmapheresis with LW-02

8:00 PM

Dinner

MIÓD MALINA

31-044 Kraków, ul. Grodzka 40

DAY 

TWO

Thursday, August 1st

8:30 AM - 9:00 AM

Registration

Session 1

9:00 AM - 9:15 AM

Welcome Speech

Adam Ostrowski

Immunicom and LW-02 Device Presentation

Amir Jafri

TNBC Study - Protocol Overview

Robert Segal & Adam Ostrowski

TNBC Study - Where we are: Poland Update

Piotr Wysocki 

Coffee Break

Procedure Challenges

Adam Ostrowski

Lunch

The Olive Restaurant at the Sheraton Grand Krakow

9:15 AM - 9:45 AM

9:45 AM - 10:15 AM

10:15 AM - 11:15 AM

11:15 AM - 11:30 AM

11:30 AM - 12:15 AM

12:15 AM - 1:00 PM

Session 2

1:00 PM - 1:20 PM

1:20 PM - 1:30 PM

1:30 PM - 1:45 PM

1:45 PM - 2:30 PM

2:30 PM - 3:00 PM

Cytokines Measurements and Analysis

Steve Prince

QoL Observations

Robert Segal & Piotr Wysocki

Looking for Target Biomarker

TBD

Patient Recruitment

Piotr Wysocki & Adam Ostrowski

Coffee Break

Session 3

3:00 PM - 3:15 PM

3:15 PM - 3:30 PM

3:30 PM - 4:15 PM

 

AGENDA

DAY 

ONE

Wednesday, July 31st

1:00 PM - 03:00 PM

Presentation of real time plasmapheresis with LW-02

DAY 

TWO

Thursday, August 1st

Thursday, August 1st

Session 1

9:00 AM - 9:15 AM

Welcome

Adam Ostrowski

Immunicom and LW-02 Device Presentation

Amir Jafri

TNBC Study - Protocol Overview

Robert Segal & Adam Ostrowski

TNBC Study - Where we are: Poland Update

Dr. Łukasz Kwinta & Piotr Wysocki

Coffee Break

Procedure Challenges

Adam Ostrowski

Lunch

The Olive Restaurant at the Sheraton Grand Krakow

9:15 AM - 9:45 AM

9:45 AM - 10:15 AM

10:15 AM - 11:15 AM

11:15 AM - 11:30 AM

11:30 AM - 12:15 PM

12:15 PM - 1:00 PM

Session 2

1:00 PM - 1:20 PM

1:20 PM - 1:30 PM

1:30 PM - 1:45 PM

1:45 PM - 2:30 PM

2:30 PM - 3:00 PM

Cytokines Measurements and Analysis

Steve Prince

QoL Observations

Robert Segal & Piotr Wysocki

Looking for Target Biomarker

TBD

Patient Recruitment

Piotr Wysocki & Adam Ostrowski

Coffee Break

Session 3

3:00 PM - 3:15 PM

3:15 PM - 3:30 PM

3:30 PM - 4:15 PM

TNBC Study Protocol Challenges and Lessons Learnt

Paweł Potocki & Piotr Wysocki

Potential New Protocols

Adam Ostrowski

TNBC Study Amendment Plan

Robert Segal & Adam Ostrowski

Activities

5:00 PM - 6:30 PM

Guided tour of Krakow

DAY 

THREE

Friday, August 2nd

8:35

3:45

"Wieliczka" Salt Mine

Wander along the trails of the phenomenally beautiful salt dungeons

Auschwitz - Birkenau Museum

Memorial and museum of former German Nazi concentration camp

Sheraton Grand Krakow

7 Powisle Street,

Krakow 31-101 Poland